Kombucha tea in cancer care: A review of its anti-cancer potential and role in integrative oncology

Sarshar, Maryam; Azmayesh, Leyla; Khoshhal, Faeze; Kabudani, Samira; Beyrami, Meysam; Rajabian, Majid; Moradi-Binabaj, Maryam; Asgharzadeh, Fereshteh

doi:10.22038/ajp.2025.26369

Kombucha tea in cancer care: A review of its anti-cancer potential and role in integrative oncology

Articles in Press

Document Type : Review Article

Authors

¹ Department of Biochemistry, Faculty of Biological Sciences, Payam Noor University of Iran, Tehran, Iran

² Department of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran

³ Department of Nutrition, Food Sciences and Clinical Biochemistry, School of Medicine, Social Determinants of Health Research Center, Gonabad University of Medical Science,Gonabad, Iran;

⁴ Applied Biomedical Research Center, Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran

10.22038/ajp.2025.26369

Abstract

Objective: The burden of cancer prevalence and mortality poses challenges to global cancer care delivery, particularly impacting low- and middle-income countries in accessing evidence-based cancer prevention, treatment, and supportive care. Integrative oncology integrates traditional, complementary, and integrative medicine with standard cancer therapies to enhance healthcare delivery. This study aims to evaluate the anti-cancer properties of kombucha tea across multiple cancer types.
Materials and Methods: Various databases, including PubMed, Science Direct, and Scopus, reviewed for recent research on kombucha tea's potential benefits and impact on cancer.
Results: Recent research developments highlight kombucha tea as a potential aid in enhancing cancer resistance and offering various health benefits.
Conclusion: Integrative oncology, complemented by the consumption of kombucha tea, presents a promising approach to addressing the complexities of cancer care. Further exploration and updates on kombucha tea anti-cancer properties against breast, lung, liver, colorectal, ovarian, uterine, and prostate cancers are warranted to enhance comprehensive understanding and potential therapeutic applications.

Keywords

Main Subjects